Many people living with rare disease describe life in terms of before and after: Before a diagnosis, they experience frustration, confusion, and exhaustion as they see various doctors and try to make sense of their symptoms. After a diagnosis, they may experience waves of relief mixed with a determination to find treatments – and often, grief about the impacts of the disease on their lives. No one understands how it feels to step across that invisible before-and-after line better than Julia Lefelar, Executive Director and Co-founder of the MOG Project.
Read MoreThe MOG Project is devoted to raising awareness about MOG Antibody Disease (MOGAD), as well as educating doctors, patients, and caregivers and also advancing research through expert collaboration and fundraising for our Research for Rare program.
Read MoreAll about Congenital Myasthenic Syndromes at a glance
Read MoreGet essential information about congenital myasthenic syndromes (CMS) and why clinical trials are a crucial element in the path towards better treatment for the condition.
Read MoreGet the basics on needle anxiety, one of the top medical fears among children, and discover tips to manage it.
Read MoreOn World Oral Health Day (March 20), we’re taking a closer look at what your oral health can tell you about your well-being.
Read MoreAuthor Erin Paterson talks about Huntington’s Disease, family planning, and the healing power of sharing your story.
Read MoreBreaking down the differences between observational studies and clinical studies for drug research.
Read MoreOrit recently joined the Know Rare business development team with the goal of helping other caregivers and patients learn more about how to engage with clinical studies and other opportunities for support. Here’s how she is reframing attitudes towards life with a rare condition.
Read MoreSpotlight on Trial Equity, an organization whose mission is to address the underrepresentation of diverse populations in clinical trials, ultimately advancing health equity.
Read MoreThe National Tay-Sachs & Allied Diseases Association (NTSAD), leader in the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1 and Sandhoff diseases, is hosting the first-ever, ExternallyLed Patient-Focused Drug Development Meeting for GM2 gangliosidoses (Tay-Sachs and Sandhoff diseases) on Thursday, February 15, 2024.
Read MoreAs we step into Rare Disease Month this February, it's an opportune time to celebrate resilience, foster connection, and empower ourselves within the rare disease community.
Read MoreIn his last post, author Chris Anselmo explored why it’s so hard to ask for help. Now, he shares his tips for how to do it with confidence.
Read MoreAn expert on adolescent health shares tips for families navigating substance use concerns alongside rare disease.
Read MoreAs we head into 2024, we’ve taken a moment to look back at some of the latest headlines in rare disease from the last year.
Read MoreHello, Adversity author Chris Anselmo delves into the common obstacles that make seeking help challenging, particularly for many people living with rare disease, and the transformative power of overcoming those mental blocks.
Read MoreEdgewise’s investigational drug is a pioneering treatment for Duchenne and Becker muscular dystrophies.
Read MoreIt’s National Influenza Vaccination Week: find out why the flu vaccine should be a critical part of your winter to-do list.
Read MoreCaitlin Eppes shares the inspiring story of The Avery Project, an initiative named after her daughter and dedicated to research of her rare genetic variant, and discusses how her family defied one-in-a-million odds to find a breakthrough in their diagnostic journey.
Read MoreHow writer Chris Anselmo confronts one of the most challenging yet persistent aspects of living with rare disease.
Read More